PositoAI/ JP/ Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

Tokyo: 4506 · Healthcare

Positivity Index

#1,087 / 8,598

Global

#72 / 1,540

Japan

Positivity Score

23,524

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Sumitomo Pharma Co., Ltd. — Overview & Financial Snapshot

Sumitomo Pharma Co., Ltd. (Tokyo: 4506) is a Healthcare company, ranked #1,087 of 8,598 companies globally and #72 of 1,540 in Japan on PositoAI, with a Positivity Score of 23,524. Its market capitalisation is ₹52,846.07 Cr (¥872.96B), P/E ratio is 8.2 and P/B ratio is 2.14. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#4 MTI Ltd. 25,225 #33 Seikagaku Corporation 23,988 #40 EM Systems Co., Ltd. 23,902 #42 Amvis Holdings, Inc. 23,875 #49 KYORIN Pharmaceutical Co., Ltd. 23,796

— Nothing to show —

OpenAI is reading recent news...

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

P/B Ratio 2.14

P/E Ratio 8.2

D/E Ratio 0.39

ROE 38.53%

Owes vs Owns ? —Not available

Dividend Yield 0.00%

Trailing EPS ₹144.48¥238.67

Forward EPS ₹10.37¥17.13

Beta 0.47

Market Cap ₹52,846.07 Cr¥872.96B

What these numbers mean →

What does Sumitomo Pharma Co., Ltd. do?

What is Sumitomo Pharma Co., Ltd.'s P/E and P/B ratio?

Sumitomo Pharma Co., Ltd. has a P/E ratio of 8.2 and a P/B ratio of 2.14.

What is Sumitomo Pharma Co., Ltd.'s debt-to-equity ratio?

Sumitomo Pharma Co., Ltd. has a debt-to-equity ratio of 0.39.

What is Sumitomo Pharma Co., Ltd.'s Positivity rank?

Sumitomo Pharma Co., Ltd. is ranked #1,087 of 8,598 companies globally and #72 of 1,540 in Japan on PositoAI, with a Positivity Score of 23,524.

Does Sumitomo Pharma Co., Ltd. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Sumitomo Pharma Co., Ltd..

Where can I read the latest news about Sumitomo Pharma Co., Ltd.?

Recent headlines about Sumitomo Pharma Co., Ltd. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Sumitomo Pharma Co., Ltd. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Sumitomo Pharma Co., Ltd.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.